Serum C terminal telopeptide maintains its correlation with bone disease in patients with myeloma even under treatment with bisphosphonates

Author： Pochintesta Lara   Mangiacavalli Silvia   Cocito Federica   Pompa Alessandra   Albertini Riccardo   Pascutto Cristiana   Ferretti Virginia Valeria   Cazzola Mario   Corso Alessandro  

Publisher： Informa Healthcare

ISSN： 1042-8194

Source： Leukemia and Lymphoma, Vol.55, Iss.6, 2014-06, pp. : 1397-1398

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The Significance of non Correlation Between Interleukin-8 Serum Levels with Bone Marrow Microvascular Density in Patients with Myeloma Multiple

By Pappa Constantina  

Pathology & Oncology Research, Vol. 19, Iss. 3, 2013-07 ,pp. : 539-543

Springer Publishing Company

Access to resources Recommend Favorite

Myeloma bone disease

By Mundy G.R.  

European Journal of Cancer, Vol. 34, Iss. 2, 1998-02 ,pp. : 246-251

Elsevier

Access to resources Recommend Favorite

Treatment options for multiple myeloma patients with high-risk disease

By Ailawadhi Sikander   Masood Aisha   Sher Taimur   Miller Kena   Wood Margaret   Lee Kelvin   Chanan-Khan Asher  

Medical Oncology, Vol. 27, Iss. 1, 2010-06 ,pp. : 53-61

Humana Press, Inc

Access to resources Recommend Favorite

Management of disease- and treatment-related complications in patients with multiple myeloma

By Gay Francesca   Palumbo Antonio  

Medical Oncology, Vol. 27, Iss. 1, 2010-06 ,pp. : 43-52

Humana Press, Inc

Access to resources Recommend Favorite

Correlation between serum high-mobility group box1 levels and high-sensitivity C-reactive protein and troponin I in patients with coronary artery disease

By            

Experimental and Therapeutic Medicine, Vol. 6, Iss. 1, 2013-01 ,pp. : 121-124

Spandidos Publications

Access to resources Recommend Favorite